Literature DB >> 2820959

Binding of high density lipoproteins to cell receptors promotes translocation of cholesterol from intracellular membranes to the cell surface.

J P Slotte1, J F Oram, E L Bierman.   

Abstract

Cultured cells have on their cell surface a specific high-affinity binding site (receptor) for high density lipoproteins (HDL) which appears to promote cholesterol efflux. In this study we characterized the cellular mechanisms involved in HDL receptor-mediated transport of cholesterol from cultured human fibroblasts and bovine aortic endothelial cells. HDL3, chemically modified by tetranitromethane (TNM-HDL3), is not recognized by this receptor and was used as a control for efflux not mediated by HDL receptor binding. HDL3 and TNM-HDL3 were found to be equally effective in causing efflux of plasma membrane cholesterol radiolabeled with [3H]cholesterol. However, HDL3 was much more effective than TNM-HDL3 in causing efflux of [3H]cholesterol associated with intracellular membranes. By measuring movement of endogenously synthesized [3H]cholesterol to the plasma membrane, and into the medium, we found that HDL3 induced a rapid movement of [3H]cholesterol from a preplasma membrane compartment to the plasma membrane that preceded [3H]cholesterol efflux. This effect was not observed with TNM-HDL3. Thus, receptor binding of HDL3 appears to facilitate removal of cellular cholesterol from specific intracellular pools by initiation of translocation of intracellular cholesterol to the plasma membrane.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2820959

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  Visualization of the uptake of high-density lipoprotein by rat aortic endothelial cells and smooth muscle cells in vitro.

Authors:  Wei T Chao; Seng S Fan; Vivian C Yang
Journal:  Histochem J       Date:  2002-05

2.  Characterization and isolation of a high-density-lipoprotein-binding protein from bovine corpus luteum plasma membrane.

Authors:  K Ferreri; K M Menon
Journal:  Biochem J       Date:  1992-11-01       Impact factor: 3.857

3.  Purification of an apolipoprotein A binding protein from mouse adipose cells.

Authors:  R Barbaras; P Puchois; J C Fruchart; A Pradines-Figueres; G Ailhaud
Journal:  Biochem J       Date:  1990-08-01       Impact factor: 3.857

4.  High glucose levels do not directly impair cellular binding of HDL3 or HDL-mediated efflux of cholesterol from human skin fibroblasts.

Authors:  P B Duell; E L Bierman
Journal:  Acta Diabetol       Date:  1991       Impact factor: 4.280

5.  Characterization and purification of proteins which bind high-density lipoprotein. A putative cell-surface receptor.

Authors:  H M Bond; G Morrone; S Venuta; K E Howell
Journal:  Biochem J       Date:  1991-11-01       Impact factor: 3.857

6.  High-density lipoproteins induce a rapid and transient release of Ca2+ in cultured fibroblasts.

Authors:  M I Pörn; K E Akerman; J P Slotte
Journal:  Biochem J       Date:  1991-10-01       Impact factor: 3.857

7.  The role of apoproteins AI and AII in binding of high-density lipoprotein3 to membranes derived from bovine aortic endothelial cells.

Authors:  P K Vadiveloo; N H Fidge
Journal:  Biochem J       Date:  1992-05-15       Impact factor: 3.857

8.  High-density lipoprotein 3 physicochemical modifications induced by interaction with human polymorphonuclear leucocytes affect their ability to remove cholesterol from cells.

Authors:  A Cogny; V Atger; J L Paul; T Soni; N Moatti
Journal:  Biochem J       Date:  1996-02-15       Impact factor: 3.857

9.  Apolipoprotein A-I variants. Naturally occurring substitutions of proline residues affect plasma concentration of apolipoprotein A-I.

Authors:  A von Eckardstein; H Funke; A Henke; K Altland; A Benninghoven; G Assmann
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

10.  Low density lipoprotein- and high density lipoprotein-mediated signal transduction and exocytosis in alveolar type II cells.

Authors:  T A Voyno-Yasenetskaya; L G Dobbs; S K Erickson; R L Hamilton
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.